Abstract
Smart implementation of novel advanced nanocarriers such as functionalized C24 and B12N12 nanocages is used supplement for antiviral activity 5-Fluoro-2-hydroxypyrazine-3-carboxamide (Favipiravir; Avigan; T-705), as treatment of COVID-19. The interaction energies of Favipiravir with perfect (B12N12 and C24) and doped (BC23 and CB11N12) nanocages were studied at temperatures equal to 310.15 K and 298.15 K using DFT. Our results have shown that the interaction of the Favipiravir (CO group) with BC23 and CB11N12 is more favorable than with the C24 and B12N12 nanocages in the gas and aqueous environments.
Additionally, the natural bond orbital, the highest occupied molecular orbital (HOMO), the lowest unoccupied molecular orbital (LUMO), energy gap, chemical reactivity, molecular electrostatic potential, and thermodynamic parameters of the optimized structure have been examined. Furthermore, the UV–Vis and infrared spectroscopy have been evaluated for the investigation of the molecular orbitals Participated in the absorption spectrum of the Favipiravir before and after the interaction with the C24, BC23, B12N12, and CB11N12, sites at maximum wavelength utilizing the time-dependent density functional theory (TD-B3LYP and TD-CAM-B3LYP). The intermolecular interactions have been analyzed by non-covalent interactions (NCI) and also, the electron localization function (ELF) is discussed.
[Display omitted]
•Favipiravir drug delivery were investigated by DFT calculation.•The interaction of the drug with the nanocage prefers to bind through the oxygen atom of the drug.•The bandgap of the nanocages was decreased after loading the drug.•Adsorption of drug on nanocage was exothermic.•The chemical reactivity is increased upon drug loading.